Table 4.
Age (mo) | Loc. | Treatment | XRT details | Chemo | Outcome | OS | Ref |
---|---|---|---|---|---|---|---|
15 | C | S (GTR), C, RT | 20 Gy CSI + 26 Gy TBB | IT MTX×3 | NED | 161 | [50] |
17 | RTP | S (GTR), C, RT | 55 Gy LF | VCR, VP-16, CDDP, CYC, CP | NED | 44 | [50] |
36 | LF | S, C, RT | Unknown | Unknown | NED | 42 | [1], [67] |
67.2 | LFT | S (GTR), C, RT | 35.2 Gy CSI, 20 Gy TBB | Per HIT91 | NED | 152.4 | [66] |
40.8 | LP | S (GTR), C, RT | 35.2 Gy CSI, 20 Gy TBB | Per HIT91 | NED | 112.8 | [66] |
67.2 | RFP | S (GTR), C, RT | 36 Gy CSI, 30 Gy TBB | Per HIT SKK2000 | DOD | 37.2 | [66] |
48 | RP | S (GTR), C, RT | 35.8 Gy CSI, 19.9 Gy TBB | CP, VCR, CYC, CDDP | NED | 84 | [78] |
7 | LTP | S (GTR), C | None | VCR, CDDP, VP-16, CYC, MTX | NED | 48 | [55] |
23 | ST | S, C, RT | Unknown | Unknown | Alive | 56 | [7] |
138 | ST | S (GTR), RT | CSI + TBB1 | None | NED | 183.9 | [69] |
34.8 | SC | S (GTR), C, RT | CSI + TBB1 | VPCP×2, HDC | NED | 43.2 | [69] |
26.4 | ST | S (GTR), C, RT | CSI + TBB1 | VPCP×2, HDC | NED | 143.6 | [69] |
38.4 | ST | S (STR), C, RT | CSI + TBB1 | VPCP×2, HDC | AWSD | 90.9 | [69] |
81.6 | ST | S (GTR), C, RT | CSI + TBB1 | VPCP×2, MP + CDDP×2 | NED | 63.8 | [69] |
24 | ST | S (STR), C, RT | CSI + TBB1 | VPCP×2, MP×2, THIO×2 | NED | 143.4 | [69] |
31.2 | ITE | S (GTR), C, RT | CSI + TBB1 | VPCP×2, HCD | NED | 103.3 | [69] |
139.2 | ITE | S, C, RT | CSI + TBB1 | VPCP×2, THIO×2, TMZ×2 | NED | 70.5 | [69] |
24 | LC, LO | S (GTR), C, RT | 32 Gy CSI, 24 Gy TBB | HRP + IT VCR, CDDP, VP-16 | NED | 52 | [80] |
S = surgery, C = chemotherapy, RT = radiotherapy, CSI = craniospinal irradiation, GTR = gross total resection, STR = subtotal resection, TBB = tumor bed boost, LF = local field, NED = no evidence of disease, DOD = died of disease, AWSD = alive with stable disease, IT = intrathecal, R = right, L = left, T = Temporal, P = parietal, F = frontal, C = cerebellum, O = occipital, ST = supratentorial, ITE = infratentorial, SC = spinal cord, MP = melphalan, VP-16 = etoposide, THIO = thiotepa, VPCP = VP-16 + CP, CP = carboplatin, CDDP = cisplatin, VCR = vincristine, CYC = cyclophosphamide, TMZ = temozolomide, HDC = MP + CDDP + THIO, HRP = 2× VCR + CYC + VP-16 → 2× VCR + CP + VP-16 → 2× VCR + CDDP + VP-16 → IT triplet ×7, ? = unspecified, 1 per protocol in Ref. [110].